MAPT and Alzheimer disease: However, comparison to tau in typical tauopathies, including various AD stages previously characterized by our lab, shows that tau in DLBTau+ patients presents a unique PTM profile, with fewer N-terminal modifications, unlike those seen in early AD [9].